AURO PHARMA INC — Ertapenem Importer Profile
Pharmaceutical Importer · #13 buyer for Ertapenem · $900.0K import value · 18 shipments · CANADA · DGFT Verified
AURO PHARMA INC is the #13 importer of Ertapenem from India with $900.0K in import value and 18 verified shipments. AURO PHARMA INC holds a 0.6% market share in Ertapenem imports based in CANADA. The company sources from 1 verified supplier across 11 formulations shipped to 1 country. Overall, AURO PHARMA INC imports 11 pharmaceutical products worth $8.9M across 4 therapeutic categories.
AURO PHARMA INC — Ertapenem Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ertapenem to AURO PHARMA INC?
Verified from 18 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| EUGIA PHARMA SPECIALITIES LIMITED | $900.0K | 18 | 100.0% |
AURO PHARMA INC sources Ertapenem from 1 verified Indian supplier based on 18 customs records. The primary supplier is EUGIA PHARMA SPECIALITIES LIMITED accounting for 100.0% of imports.
How Does AURO PHARMA INC Compare to Nearest Ertapenem Importers?
Buyers ranked immediately above and below #13 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 16 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $700.0K | 14 | $50.0K |
| 5 | OOOJODAS EXPOIM | RUSSIA | $650.0K | 13 | $50.0K |
| 13 | AURO PHARMA INC ★ | CANADA | $650.0K | 13 | $50.0K |
| 14 | EUGIA PHARMA (MALTA) LIMITED | MALTA | $650.0K | 13 | $50.0K |
| 15 | APL SWIFT SERVICES MALTA LTD | MALTA | $550.0K | 11 | $50.0K |
AURO PHARMA INC ranks #13 among 137 Ertapenem importers from India. Average shipment value of $50.0K compared to the market average of $181.0K. The closest competitors by value are YUSEN LOGISTICS BENELUX BELGIUM and OOOJODAS EXPOIM.
Where Does AURO PHARMA INC Import Ertapenem To?
Destination countries from 18 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $900.0K | 18 | 100.0% |
AURO PHARMA INC imports Ertapenem to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $900.0K.
What Ertapenem Formulations Does AURO PHARMA INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| ERTAPENEM FOR INJECTION 1G/VIAL(ERTAPENE | $200.0K | 4 |
| ERTAPENEM FOR INJECTION 1G/VIAL ( ERTAPE | $200.0K | 4 |
| ERTAPENEM FOR INJECTION 1 G VIAL ERTAPENEM FOR INJECTION 1G VIAL B N 2EI23005A MFG DT 01 2023 EXP DT 12 2024 | $100.0K | 2 |
| ERTAPENEM FOR INJECTION 1 G/VIAL,(ERTAPE | $50.0K | 1 |
| ERTAPENEM FOR INJECTION 1 G/VIAL, (ERTAP | $50.0K | 1 |
| ERTAPENEM FOR INJECTION 1 G/VIAL(ERTAPE | $50.0K | 1 |
| ERTAPENEM FOR INJECTION 1G/VIAL,(Ertapen | $50.0K | 1 |
| ERTAPENEM FOR INJECTION 1 G/VIAL (ERTAPE | $50.0K | 1 |
| ERTAPENEM FOR INJECTION 1 G VIAL ERTAPENEM FOR INJECTION 1G VIAL B N 2EI23018A MFG DT 02 2023 EXP DT 01 2025 | $50.0K | 1 |
| ERTAPENEM FOR INJECTION 1 G VIAL ERTAPENEM FOR INJECTION 1G VIAL B N 2EI23016A MFG DT 02 2023 EXP DT 01 2025 | $50.0K | 1 |
AURO PHARMA INC imports 11 distinct Ertapenem formulations from India. The top formulation is ERTAPENEM FOR INJECTION 1G/VIAL(ERTAPENE with 4 shipments worth $200.0K.
Regulatory Requirements: Importing Ertapenem into Canada
What AURO PHARMA INC and other importers must comply with to import Ertapenem from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Ertapenem
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ertapenem from India and How Much Does AURO PHARMA INC Import?
India exported $24.8M worth of Ertapenem through 780 shipments from 54 suppliers to 46 countries, serving 137 buyers globally. AURO PHARMA INC imports $900.0K of this total, accounting for 0.6% of India's Ertapenem exports with 18 shipments from CANADA. This is verified from 18 customs shipment records covering 11 distinct formulations.
What Is the Average Order Value for AURO PHARMA INC's Ertapenem Imports?
AURO PHARMA INC's average Ertapenem order value is $50.0K per consignment, based on 18 shipments totaling $900.0K. AURO PHARMA INC is based in CANADA and ranks #13 among all Ertapenem importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ertapenem to AURO PHARMA INC?
AURO PHARMA INC sources Ertapenem from 1 verified Indian supplier: EUGIA PHARMA SPECIALITIES LIMITED ($900.0K, 100.0%). This is based on 18 customs records.
How Does AURO PHARMA INC Compare to Other Ertapenem Importers?
AURO PHARMA INC ranks #13 among 137 Ertapenem importers from India with a 0.6% market share. The top 3 importers are EUGIA US LLC, ($5.6M), EUGIA US LLC ($5.5M), AUROMEDICS PHARMA, LLC, ($2.5M). AURO PHARMA INC processed 18 shipments from CANADA.
What Other Advanced Antibiotics Products Does AURO PHARMA INC Import?
AURO PHARMA INC also imports these advanced antibiotics products. Each links to the detailed product page.
About AURO PHARMA INC
AURO PHARMA INC imports 11 products worth $8.9M. Beyond Ertapenem, top products include Sertraline, Cefixime, Dapagliflozin, Escitalopram, Repaglinide. View the complete AURO PHARMA INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ertapenem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ertapenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AURO PHARMA INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AURO PHARMA INC's capped import value divided by total capped export value for Ertapenem across all Indian exporters.
- 5.Verified Records: This page is backed by 18 individual customs records matching AURO PHARMA INC importing Ertapenem, covering 11 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 46+ countries, 137+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ertapenem Import Data for AURO PHARMA INC
Access order-level details, pricing data, supplier connections, and competitive analysis for AURO PHARMA INC's Ertapenem imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AURO PHARMA INC
Full Company Profile →
11 products · $8.9M total trade · 4 categories
AURO PHARMA INC × Ertapenem
Verified from customs records
Company Overview
Top Products by AURO PHARMA INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AURO PHARMA INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ertapenem. For current order-level data, contact TransData Nexus.